Show simple item record

dc.contributor.authorKaren-Ng, LP
dc.contributor.authorJames, EL
dc.contributor.authorStephen, A
dc.contributor.authorBennett, MH
dc.contributor.authorMycielska, ME
dc.contributor.authorParkinson, EK
dc.date.accessioned2021-09-06T16:03:12Z
dc.date.available2021-08-16
dc.date.available2021-09-06T16:03:12Z
dc.date.issued2021-08-21
dc.identifier.citationKaren-Ng, L.P.; James, E.L.; Stephen, A.; Bennett, M.H.; Mycielska, M.E.; Parkinson, E.K. The Extracellular Metabolome Stratifies Low and High Risk Potentially Premalignant Oral Keratinocytes and Identifies Citrate as a Potential Non-Invasive Marker of Tumour Progression. Cancers 2021, 13, 4212. https://doi.org/10.3390/cancers13164212en_US
dc.identifier.issn2072-6694
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/73905
dc.description.abstractPremalignant oral lesions (PPOLs) which bypass senescence (IPPOL) have a much greater probability of progressing to malignancy, but pre-cancerous fields also contain mortal PPOL keratinocytes (MPPOL) that possess tumour-promoting properties. To identify metabolites that could potentially separate IPPOL, MPPOL and normal oral keratinocytes non-invasively in vivo, we conducted an unbiased screen of their conditioned medium. MPPOL keratinocytes showed elevated levels of branch-chain amino acid, lipid, prostaglandin, and glutathione metabolites, some of which could potentially be converted into volatile compounds by oral bacteria and detected in breath analysis. Extracellular metabolites were generally depleted in IPPOL, and only six were elevated, but some metabolites distinguishing IPPOL from MPPOL have been associated with progression to oral squamous cell carcinoma (OSCC) in vivo. One of the metabolites elevated in IPPOL relative to the other groups, citrate, was confirmed by targeted metabolomics and, interestingly, has been implicated in cancer growth and metastasis. Although our investigation is preliminary, some of the metabolites described here are detectable in the saliva of oral cancer patients, albeit at a more advanced stage, and could eventually help detect oral cancer development earlier.en_US
dc.languageeng
dc.publisherMDPIen_US
dc.relation.ispartofCancers (Basel)
dc.rightsCreative Commons Attribution License
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectdiagnosticsen_US
dc.subjectmetabolismen_US
dc.subjectoral premalignancyen_US
dc.subjectsenescenceen_US
dc.subjecttumour heterogeneityen_US
dc.subjecttumour progressionen_US
dc.titleThe Extracellular Metabolome Stratifies Low and High Risk Potentially Premalignant Oral Keratinocytes and Identifies Citrate as a Potential Non-Invasive Marker of Tumour Progression.en_US
dc.typeArticleen_US
dc.identifier.doi10.3390/cancers13164212
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/34439366en_US
pubs.issue16en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume13en_US
dcterms.dateAccepted2021-08-16
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderDeveloping a marker for ageing cells: can we identify and reverse the age-related disease::Dunhill Medical Trusten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution License
Except where otherwise noted, this item's license is described as Creative Commons Attribution License